HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
At Regional Cancer Care Associates in New Jersey, Maryland and Connecticut, you will receive cancer treatment from physicians and clinical staff who dedicate themselves to your needs. An important part of our commitment to you and your family is making it as easy as possible for you to get and benefit from state-of-the-art cancer care. The other part is delivering you this care with the compassion, support and efficiency you and your family deserve.
We’re here for you. Call us at 844-346-7222 or
25 convenient locations to serve you across NJ, MD and CT.
If you have cancer and live in New Jersey, Maryland or Connecticut, you don’t need to travel out of town to get the state-of-the-art treatments and top-quality care you need to fight cancer effectively. RCCA has 25 different locations across these three states, each providing the most experienced and advanced care… with an uncommonly local, individualized and compassionate approach. This means you will enjoy more responsive and nimble cancer care providers. And our doctors can see you at any of the many different hospitals in and around your communities.
Be seen quickly, and get started sooner.
At RCCA, it is a priority to see you for your initial appointment as soon as possible when you are newly diagnosed with cancer. Usually, this is within just two days. If you are an existing patient, you are accommodated as soon as possible, and typically you are seen much sooner than at other cancer-treatment facilities. While we always recommend you see your own primary care physician, if you have urgent needs and your doctor isn’t available to see you, you may see one of our medical professionals.
Here are some of the other ways RCCA makes your cancer care more accessible:
We believe in “speaking your language.”
Offices conveniently located to you and getting you in for an appointment quickly are not all there is to accessible care. Communication with you is, of course, centrally important for your cancer care. All your care team — doctors, patient, nursing staff, caregivers — must communicate… and then engage with you and your family. We strive to provide information in terms you will understand, not just “doctor-speak.”
At the same time, chances are good that we really do speak your language, because we are as diverse as the communities we serve and the people we care for. If we don’t have personnel to assist your communication, RCCA provides free language services to people whose primary language is not English, such as:
These resources can be accessed by calling 844-346-7222 or by emailing languageassistance@regionalcancercare.org. Here are the many different languages we can assist with:
For more information, or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Our priorities and objectives are guided by a board of physicians making clinically based decisions that are always in patients’ best interests. LEARN MORE
Get to know the dedicated professionals handling all aspects of our business in pursuit of the highest standards of clinical care. LEARN MORE
At our 24 community-based care centers, our oncologists and hematologists draw on their deep experience to treat the full range of solid tumors, blood-based malignancies, and non-cancer blood disorders. LEARN MORE
For more information, or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.